Clearance Summary
HUMAN LUNG CARCINOMA CELLS (A549) received FDA 510(k) clearance under submission number K861373, sponsored by Viromed Laboratories, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1986-04-18.
- Submission: K861373
- Applicant / Sponsor: Viromed Laboratories, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class I
- Regulation citation: 21 CFR 864.2280
- Decision date: 1986-04-18
Classification & Regulation
This clearance is catalogued under FDA product code KIR and 21 CFR 864.2280, within the Hematology review panel as a Class I device.